A total of 50 patients with metastatic colorectal cancer will be enrolled in the study. The patients were randomly divided into the WLS-intervention group and the control group. The two groups of patients were given the most appropriate medication according to the specific conditions of the disease. Patients in the intervention group received additional oral administration of Weileshu, a probiotics product (Tongchuang Biotechnology).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
a probiotics products which help to rebuild homeostasis of gut microbiome
chemotherapy
First affiliated hospital, Zhejiang University
Hangzhou, Zhejiang, China
progression free survival
time from randomization to progression
Time frame: up to approximately half a year
overall survival
time from randomization to death
Time frame: up to approximately two years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.